These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24773565)

  • 21. Vitamin D receptor ligands for osteoporosis.
    Cheskis BJ; Freedman LP; Nagpal S
    Curr Opin Investig Drugs; 2006 Oct; 7(10):906-11. PubMed ID: 17086935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of fluorines on nonsecosteroidal vitamin D receptor agonists.
    Kashiwagi H; Ohta M; Ono Y; Morikami K; Itoh S; Sato H; Takahashi T
    Bioorg Med Chem; 2013 Feb; 21(3):712-21. PubMed ID: 23266184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel 1alpha,25-dihydroxyvitamin D3 analogues with the side chain at C12.
    González-Avión XC; Mouriño A; Rochel N; Moras D
    J Med Chem; 2006 Mar; 49(5):1509-16. PubMed ID: 16509569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-based design of a superagonist ligand for the vitamin D nuclear receptor.
    Hourai S; Rodrigues LC; Antony P; Reina-San-Martin B; Ciesielski F; Magnier BC; Schoonjans K; Mouriño A; Rochel N; Moras D
    Chem Biol; 2008 Apr; 15(4):383-92. PubMed ID: 18420145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis for the accommodation of bis- and tris-aromatic derivatives in vitamin D nuclear receptor.
    Ciesielski F; Sato Y; Chebaro Y; Moras D; Dejaegere A; Rochel N
    J Med Chem; 2012 Oct; 55(19):8440-9. PubMed ID: 22957834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Applications of the Vitamin D sterol-Vitamin D receptor (VDR) conformational ensemble model.
    Mizwicki MT; Bishop JE; Norman AW
    Steroids; 2005; 70(5-7):464-71. PubMed ID: 15862832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of Nuclear Receptor Ligands and Elucidation of Their Mechanisms of Action.
    Yamamoto K
    Chem Pharm Bull (Tokyo); 2019; 67(7):609-619. PubMed ID: 31257315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic applications for novel non-hypercalcemic vitamin D receptor ligands.
    Choi M; Makishima M
    Expert Opin Ther Pat; 2009 May; 19(5):593-606. PubMed ID: 19441936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, evaluation, and structure of vitamin D analogues with furan side chains.
    Fraga R; Zacconi F; Sussman F; Ordóñez-Morán P; Muñoz A; Huet T; Molnár F; Moras D; Rochel N; Maestro M; Mouriño A
    Chemistry; 2012 Jan; 18(2):603-12. PubMed ID: 22162241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical role of helix 12 of the vitamin D(3) receptor for the partial agonism of carboxylic ester antagonists.
    Väisänen S; Peräkylä M; Kärkkäinen JI; Steinmeyer A; Carlberg C
    J Mol Biol; 2002 Jan; 315(2):229-38. PubMed ID: 11779241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic and ligand-selective interactions of vitamin D receptor with retinoid X receptor and cofactors in living cells.
    Choi M; Yamada S; Makishima M
    Mol Pharmacol; 2011 Dec; 80(6):1147-55. PubMed ID: 21917910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction.
    Eelen G; Verlinden L; Rochel N; Claessens F; De Clercq P; Vandewalle M; Tocchini-Valentini G; Moras D; Bouillon R; Verstuyf A
    Mol Pharmacol; 2005 May; 67(5):1566-73. PubMed ID: 15728261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structure of a vitamin D3 analog, ZK203278, showing dissociated profile.
    Rochel N; Moras D
    Anticancer Res; 2012 Jan; 32(1):335-9. PubMed ID: 22213324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic application of vitamin D receptor ligands: an updated patent review.
    Takada I; Makishima M
    Expert Opin Ther Pat; 2015; 25(12):1373-83. PubMed ID: 26402335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and structure-activity relationship of p-carborane-based non-secosteroidal vitamin D analogs.
    Fujii S; Kano A; Songkram C; Masuno H; Taoda Y; Kawachi E; Hirano T; Tanatani A; Kagechika H
    Bioorg Med Chem; 2014 Feb; 22(4):1227-35. PubMed ID: 24486205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noncalcemic actions of vitamin D receptor ligands.
    Nagpal S; Na S; Rathnachalam R
    Endocr Rev; 2005 Aug; 26(5):662-87. PubMed ID: 15798098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-function relationships of vitamin D including ligand recognition by the vitamin D receptor.
    Yamada S; Shimizu M; Yamamoto K
    Med Res Rev; 2003 Jan; 23(1):89-115. PubMed ID: 12424754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin D receptor ligands: the impact of crystal structures.
    Carlberg C; Molnár F; Mouriño A
    Expert Opin Ther Pat; 2012 Apr; 22(4):417-35. PubMed ID: 22449247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 13,13-Dimethyl-des-C,D analogues of (20S)-1α,25-dihydroxy-2-methylene-19-norvitamin D₃ (2MD): total synthesis, docking to the VDR, and biological evaluation.
    Plonska-Ocypa K; Sibilska I; Sicinski RR; Sicinska W; Plum LA; DeLuca HF
    Bioorg Med Chem; 2011 Dec; 19(23):7205-20. PubMed ID: 22018918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
    Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
    Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.